Mechanism of gemcitabine-induced apoptosis |
Seol, Jae-Won
(Center for Healthcare Technology Development, College of Veterinary Medicine, Chonbuk National University)
Lee, You-Jin (Center for Healthcare Technology Development, College of Veterinary Medicine, Chonbuk National University) Kang, Dong-Won (Center for Healthcare Technology Development, College of Veterinary Medicine, Chonbuk National University) Kang, Hyung-Sub (Center for Healthcare Technology Development, College of Veterinary Medicine, Chonbuk National University) Kim, Nam-Soo (Center for Healthcare Technology Development, College of Veterinary Medicine, Chonbuk National University) Kim, In-Shik (Center for Healthcare Technology Development, College of Veterinary Medicine, Chonbuk National University) Park, Sang-Youel (Center for Healthcare Technology Development, College of Veterinary Medicine, Chonbuk National University) |
1 | Alnemri ES. Mammalian cell death proteases: a family of highly conserved aspartate specific cysteine proteases. J Cell Biochem 1997, 64, 33-42 DOI PUBMED ScienceOn |
2 | Bandala E, Espinosa M, Maldonado V, Melendez-Zajgla J. Inhibitor of apoptosis-1 (IAP-1) expression and apoptosis in non-small-cell lung cancer cells exposed to gemcitabine. Biochem Pharmacol 2001, 62, 13-19 DOI PUBMED ScienceOn |
3 | Cartee L, Kucera GL, Willingham MC. Induction of apoptosis by gemcitabine in BG-1 human ovarian cancer cells compared with induction by staurosporine, paclitaxel and cisplatin. Apoptosis 1998, 3, 439-449 DOI ScienceOn |
4 | Maier D, Jones G, Li X, Schonthal AH, Gratzl O, Van Meir EG, Merlo A. The PTEN lipid phosphatase domain is not required to inhibit invasion of glioma cells. Cancer Res 1999, 59, 5479-5482 |
5 | Mosconi AM, Crino L, Tonato M. Combination therapy with gemcitabine in non-small cell lung cancer. Eur J Cancer 1997, 33 Suppl 1, S14-17 |
6 | Nagata S. Apoptosis by death factor. Cell 1997, 88, 355-365 DOI PUBMED ScienceOn |
7 | Noble S, Goa KL. Gemcitabine. A review of its pharmacology and clinical potential in non-small cell lung cancer and pancreatic cancer. Drugs 1997, 54, 447-472 DOI ScienceOn |
8 | Silver DF, Piver MS. Gemcitabine salvage chemotherapy for patients with gynecologic malignancies of the ovary, fallopian tube, and peritoneum. Am J Clin Oncol 1999, 22, 450-452 DOI ScienceOn |
9 | Ashkenazi A, and Dixit VM. Death receptors: signaling and modulation. Science 1998, 281, 1305-1308 DOI PUBMED ScienceOn |
10 | Kerr JF. Shrinkage necrosis: a distinct mode of cellular death. J Pathol 1971, 105, 13-20 DOI PUBMED |
11 | Habiro A, Tanno S, Koizumi K, Izawa T, Nakano Y, Osanai M, Mizukami Y, Okumura T, Kohgo Y. Involvement of p38 mitogen-activated protein kinase in gemcitabine-induced apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun 2004, 316, 71-77 DOI ScienceOn |
12 | Pourquier P, Gioffre C, Kohlhagen G, Urasaki Y, Goldwasser F, Hertel LW, Yu S, Pon RT, Gmeiner WH, Pommier Y. Gemcitabine (2',2'-difluoro-2'-deoxycytidine), an antimetabolite that poisons topoisomerase I. Clin Cancer Res 2002, 8, 2499-2504 |
13 | Chen M, Hough AM, Lawrence TS. The role of p53 in gemcitabine-mediated cytotoxicity and radiosensitization. Cancer Chemother Pharmacol 2000, 45, 369-374 DOI ScienceOn |
14 | Kerr JF, Wyllie AH., Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26, 239-257 DOI ScienceOn |
15 | Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91, 479-489 DOI ScienceOn |
16 | Chang GC, Hsu SL, Tsai JR., Wu WJ, Chen CY, Sheu GT. Extracellular signal-regulated kinase activation and Bcl-2 downregulation mediate apoptosis after gemcitabine treatment partly via a p53-independent pathway. Eur J Pharmacol 2004, 502, 169-183 DOI ScienceOn |
17 | Chandler NM, Canete JJ, Callery MP. Caspase-3 drives apoptosis in pancreatic cancer cells after treatment with gemcitabine. J Gastrointest Surg 2004, 8, 1072-1078 DOI ScienceOn |
18 | Nabhan C, Gajria D, Krett NL, Gandhi V, Ghias K, Rosen ST. Caspase activation is required for gemcitabine activity in multiple myeloma cell lines. Mol Cancer Ther 2002, 1, 1221-1227 |
19 | Lim ML, Lum MG, Hansen TM, Roucou X, Nagley P. On the release of cytochrome c from mitochondria during cell death signaling. J Biomed Sci 2002, 9, 488-506 |
20 | Boldin MP, Goncharov TM, Goltsev YV, Wallach D. Involvement of MACH, a novel MORT1/FADDinteracting protease, in Fas/APO-1- and TNF receptorinduced cell death. Cell 1996, 85, 803-815 DOI ScienceOn |
21 | Minn AJ, Velez P, Schendel SL, Liang H, Muchmore SW, Fesik SW, Fill M, Thompson CB. Bcl-x(L) forms an ion channel in synthetic lipid membranes. Nature 1997, 385, 353-357 DOI ScienceOn |
22 | Muchmore SW, Sattler M, Liang H, Meadows RP, Harlan JE, Yoon HS, Nettesheim D, Chang BS, Thompson CB, Wong SL, Ng SL, Fesik SW. X-ray and NMR structure of human Bcl-xL, an inhibitor of programmed cell death. Nature 1996, 381, 335-341 DOI ScienceOn |
23 | Lobo F, Virizuela JA, Dorta FJ, Florian J, Lomas M, Jimenez E, Lopez P, Casado V, Leon A, Estevez LG, Domine M. Gemcitabine/vinorelbine in metastatic breast cancer patients previously treated with anthracyclines: results of a phase II trial. Clin Breast Cancer 2003, 4, 46-50 DOI ScienceOn |